Abstract
The antigen recognition potential of lymphocytes is theoretically so vast that, without appropriate regulation, the immune system should inevitably react to self-antigens. The development of B and T lymphocytes is therefore controlled at multiple levels in order to ensure that individuals will be able to respond to a large array of foreign antigens while being tolerant to self. Under some circumstances, the encounter between a foreign antigen and a naive lymphocyte will result in the emergence of a clonal population of effector cells able to eliminate this antigen. Such activation-induced positive selection not only involves the antigen-dependent step, but also depends on the differentiation state of the cell, and often requires additional stimuli from the environment. By contrast, activation-induced negative selection of lymphocytes refers essentially to the process whereby the immune system eliminates potentially harmful self-reactive lymphocytes. Again, the state of differentiation of lymphocytes and/or environmental signals play a critical role in this self-tolerance process. Viewed in this way, the distinction between activation-induced positive and negative selection is not straightforward. However, studies conducted recently had shed new light on this area and contribute to a better understanding of the underlying processes which keep the immune system under control.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Alderson MR, Armitage FU, Maraskovsky E, Tough TW, Roux E, Schooley K, Ramsdell F, Lynch DH (1993) Fas transduces activation signals in normal human T-lymphocytes. J Exp Med 178: 2231–2235
Ales-Martinez JE, Warner GL, Scott DW (1988) Immunoglobulins D and M mediate signals that are qualitatively different in B cells with an immature phenotype. Proc Natl Acad Sci USA 85: 6919–6923
Ales-Martinez JE, Silver L, LoCascio N, Scott DW (1991) Lymphoma models for B-cell activation and tolerance. IX. Efficient reversal of anti-Ig-mediated growth inhibition by an activated TH2 clone. Cell Immunol 135: 402–409
Alexander D, Shiroo M, Robinson A, Biffen M, Shivnan E (1992) The role of CD45 in T-Cell activation: resolving the paradoxes. Immunol Today 13: 477–481
Askew D, Ashmun R, Simmons B, Cleveland J (1991) Constitutive c-myc expression in IL-3-dependent myeloid cell lines suppresses cycle arrest and accelerates apoptosis. Oncogene 6: 1915–1922
Bachmann MF, Rohrer UH, Kundig TM, Burki K, Hengartner H, Zinkernagel RM (1993) The influence of antigen organization on B-cell responsiveness. Science 262: 1448–1451
Baixeras E, Kroemer G, Cuende E, Marquez C, Bosca L, Martinez JEA, Martinez AC (1993) Signal transduction pathways involved in B-cell induction. Immunol Rev 132: 5–47
Benhamou LE, Cazenave P-A, Sarthou P (1990) Anti-immunoglobulins induce death by apoptosis in WEHI-231 B lymphoma cells. Eur J Immunol 20: 1405–1407
Benhamou LE, Watanabe T, Kitamura D, Cazenave P-A, Sarthou P (1994) Signaling properties of anti immunoglobulin resistant variants of WEHI-231. Eur J Immunol 24: 1993–1999
Bijsterbosch MK, Klaus GGB (1987) Tumor-promoting phorbol esters suppress receptor-stimulated inositol phospholipid degradation and Ca2+ mobilization in mouse lymphocytes, Eur J Immunol 17: 113–118
Bishop GA, Ramirez LM, Koretzky GA (1993) Growth inhibition of a B-cell clone mediated by ligation of IL-4 receptors or membrane IgM. J Immunol 150: 2565–2574
Bonnefoy JY, Henchoz S, Hardie D, Holder MJ, Gordon J (1993) A subset of anti-CD21 antibodies promote the rescue of germinal center B-cells from apoptosis. Eur J Immunol 23: 969–972
Bonnefoy-Berard N, Genestier L, Flacher M, Revillard JP (1994) The phosphoprotein phosphatase Calcineurin controls calcium-dependent apoptosis in B cell lines. Eur J Immunol 24: 325–329
Bossy D, Salamero J, Olive D, Fougereau M, Schiff C (1993) Structure, biosynthesis, and transduction properties of the human mu-psi-L complex: similar behavior of preB and intermediate preB-B cells in transducing ability. Int Immunol 5: 467–478
Brines RD, Klaus GGB (1991) Effects of anti-immunoglobulin antibodies, interleukin-4 and second messenger agonists on B-cells from neonatal mice. Int Immunol 3: 461–466
Brines RD, Klaus GGB (1992) Inhibition of lipopolysaccharide-induced activation of immature B-cells by anti-mu and anti-delta antibodies and its modulation by interleukin-4. Int Immunol 4: 765–771
Brines RD, Klaus GGB (1993) Polyclonal activation of immature B-cells by preactivated T-cells: the role of IL-4 and CD40-ligand. Int Immunol 5: 1445–1450
Brink R, Goodnow CC, Crosbie J, Adams E, Eris J, Mason DY, Hartley SB, Basten A (1992) Immunoglobulin-M and immunoglobulin-D antigen receptors are both capable of mediating lymphocyte-B activation, deletion, or anergy after interaction with specific antigen. J Exp Med 176: 991–1005
Brouns GS, Devries E, Vannoesel CJM, Mason DY, Vanlier RAW, Borst J (1993) The structure of the mu/pseudo light chain complex on human pre-B cells is consistent with a function in signal transduction. Eur J Immunol 23: 1088–1097
Brunswick M, Finkelman FD, Highet PF, Inman JK, Dintzis HM, Mond JJ (1988) Picogram quantities of anti-Ig antibodies coupled to dextran induce B cell proliferation. J Immunol 140: 3364–3372
Callard RE, Armitage RJ, Fanslow WC, Spriggs MK (1993) CD40 ligand and its role in X-linked hyper-IgM syndrome. Immunol Today 14: 559–564
Cambier JC, Bedzyk W, Campbell K, Chien N, Friedrich J, Harwood A, Jensen W, Pleiman C, Clark MR (1993) The B-cell antigen receptor: structure and function of primary, secondary, tertiary and quaternary components. Immunol Rev 132: 85–106
Carsetti R, Kohler G, Lamers MC (1993) A role for immunoglobulin-D: interference with tolerance induction. Eur J Immunol 23: 168–178
Chang TL, Capraro G, Kleinman RE, Abbas AK (1991) Anergy in immature lymphocytes-B: differential responses to receptor-mediated stimulation and T-helper cells. J Immunol 147: 750–756
Clark EA, Ledbetter JA (1994) How B and T cells talk to each other. Nature 367: 425–428
Cohen JJ, Duke RC, Fadok VA, Sellins KS (1992) Apoptosis and programmed cell death in immunity. Annu Rev Immunol 10: 267–293
Cooke MP, Heath AW, Shokat KM, Zeng YJ, Finkelman FD, Linsley PS, Howard M, Goodnow CC (1994) Immunoglobulin signal transduction guides the specificity of B cell-T cell interactions and is blocked in tolerant self-reactive B cells. J Exp Med 179: 425–438
Cuende E, Kroemer G, Alonso JM, Nemazee D, Martinez C, Ales-Martinez JE (1992) Inability of IL-2 and IL-10 to counteract B-cell clonal deletion. Cell Immunol 142: 94–102
Cuende E, Ales-Martinez JE, Ding LY, Gonzalez-Garcia M, Martinez- A. C, Nunez G (1993) Programmed cell death by bcl-2-dependent and independent mechanisms in B-lymphoma cells. EMBO J 12: 1555–1560
Dancescu M, Rubiotrujillo M, Biron G, Bron D, Delespesse G, Sarfati M (1992) Interleukin-4 protects chronic lymphocytic leukemic B-cells from death by apoptosis and upregulates Bcl-2 expression. J Exp Med 176: 1319–1326
Desiderio S (1994) The B cell antigen receptor in B-cell development. Curr Opin Immunol 6: 248–256
Evan GI, Littlewood TD (1993) The role of c-myc in cell growth. Curr Opin Genet Dev 3: 44–49
Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M, Waters CM, Penn LZ, Hancock DC (1992) Induction of apoptosis in fibroblasts by c-myc protein. Cell 69: 119–128
Fanidi A, Harrington EA, Evan GI (1992) Cooperative interaction between c-myc and bcl-2 proto-oncogenes. Nature 359: 554–556
Fearon DT (1993) The CD19-CR2 TAPA-1 complex, CD45 and signaling by the antigen receptor of B-lymphocytes. Curr Opin Immunol 5: 341–348
Fischer G, Kent SC, Joseph L, Green DR, Scott DW (1994) Lymphoma models for B cell activation and tolerance. 10. Anti-mu-mediated growth arrest and apoptosis of murine B cell lymphomas is prevented by the stabilization of myc. J Exp Med 179: 221–228
Fluckiger AC, Durand I, Banchereau J (1994) Interleukin 10 induces apoptotic cell death of B-chronic lymphocytic leukemia cells. J Exp Med 179: 91–99
Fukuda T, Kitamura D, Taniuchi I, Maekawa Y, Benhamou LE, Sarthou P, Watanabe T (1994) Complementation by the HS1 protein of a mutant B cell line resistant to anti-IgM induced apoptosis (submitted)
Gaur A, Yao XR, Scott DW (1993) B-cell tolerance induction by cross-linking of membrane IgM, but not IgD, and synergy by cross-linking of both isotypes. J Immunol 150: 1663–1669
Gay D, Saunders T, Camper S, Weigert M (1993) Receptor editing: an approach by autoreactive B-cells to escape tolerance. J Exp Med 177: 999–1008
Gold MR, DeFranco AL (1987) Phorbol esters and dioctanoylglycerol block anti-IgM-stimulated phosphoinositide hydrolysis in the murine B cell lymphoma WEHI-231. J Immunol 138: 868–876
Goodnow CC (1992)Transgenic mice and analysis of B-cell tolerance. Annu Rev Immunol 10: 489–518
Goodnow CC, Crosbie J, Adelstein S, Lavoie TB, Smith Gill SJ, Brink RA, Pritchard-Briscoe H, Wotherspoon JS, Loblay RH, Raphael K, Trent RJ, Basten A (1988) Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature 334: 676–682
Gottschalk AR, McShan CL, Merino R, Nunez G, Quintans J (1994) Physiological cell death in B lymphocytes. 1. Differential susceptibility of WEHI-231 sublines to anti-Ig induced physiological cell death and tack of correlation with Bcl-2 expression. Int Immunol 6: 121–130
Green DR, Bissonnette RP, Glynn JM, Shi Y (1992) Activation-induced apoptosis in lymphoid systems. Semin Immunol 4: 379–388
Haggerty HG, Monroe JG (1994) Mutant of the WEHI-231 B lymphocyte line that is resistant to phorbol esters is still sensitive to antigen receptor-mediated growth inhibition. Cell Immunol 154: 166–180
Haggerty HG, Wechsler RJ, Lentz VM, Monroe JG (1993) Endogenous expression of delta on the surface of WEHI-231 characterization of its expression and signaling properties. J Immunol 151: 4681–4693
Harada N, Yang G, Miyajima A, Howard M (1992) Identification of an essential region for growth signal transduction in the cytoplasmic domain of the human interleukin-4 receptor. J Biol Chem 267: 22752–22758
Harnett MM, Holman MJ, Klaus GGB (1991) IL-4 promotes anti-Ig-mediated protein kinase-C translocation and reverses phorbol ester-mediated protein kinase-C down-regulation in murine B cells. J Immunol 147: 3831–3836
Hartley SB, Crosbie J, Brink R, Kantor AB, Basten A, Goodnow CC (1991) Elimination from peripheral lymphoid tissues of self-reactive lymphocytes-B recognizing membrane-bound antigens. Nature 353: 765–769
Hartley SB, Cooke MP, Fulcher DA, Harris AW, Cory S, Basten A, Goodnow CC (1993) Elimination of self-reactive iymphocytes-B proceeds in 2 stages. Arrested development and cell death. Cell 72: 325–335
Hasbold J, Klaus GGB (1990) Anti-immunoglobulin antibodies induce apoptosis in immature B lymphomas. Eur J Immunol 20: 1685–1690
Hibner U, Coutinho A (1994) Signal antinomy: a mechanism for apoptosis induction. Cell Death Differ 1: 33–37
Hibner U, Benhamou LE, Haury M, Cazenave PA, Sarthou P (1993) Signaling of programmed cell death induction in WEHI-231 B lymphoma cells. Eur J Immunol 23: 2821–2825
Hockenberry DM, Zutter M, Hickley W, Nahm M, Korsmeyer SJ (1991) Bcl-2 protein is topologically restricted in tissues characterized by apoptotic cell death. Proc Natl Acad Sci USA 88: 6961–6965
Hockenbery DM, Oltvai ZN, Yin XM, Milliman CL, Korsmeyer SJ (1993) Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75: 241–251
Holder MJ, Wang H, Milner AE, Casamayor M, Armitage R, Spriggs MK, Fanslow WC, MacLennan ICM, Gregory CD, Gordon J (1993) Suppression of apoptosis in normal and neoplastic human B-lymphocytes by CD40 ligand is independent of Bcl-2 induction. Eur J Immunol 23: 2368–2371
Illera VA, Perandones CE, Stunz LL, Mower DA, Ashman RF (1993) Apoptosis in splenic lymphocytes-B: regulation by protein kinase-C and IL-4. J Immunol 151: 2965–2973
Ishihara K, Wood WJ, Wall R, Sakaguchi N, Michnoff C, Tucker PW, Kincade PW (1993) Multiple B29 containing complexes on murine B-lymphocytes: common and stage restricted lg-associated polypeptide chains. J Immunol 150: 2253–2262
Itoh N, Tsujimoto Y, Nagata S (1993) Effect of bcl-2 on Fas antigen-mediated cell death. J Immunol 151: 621–627
Jongstra J, Misener V (1993) Developmental maturation of the B-cell antigen receptor. Immunol Rev 132: 107–123
Justement LB, Campbell KS, Chien NC, Cambier JC (1991) Regulation of B-cell antigen receptor signal transduction and phosphorylation by CD45. Science 252: 1839–1842
Kamesaki H, Zwiebel JA, Reed JC, Cossman J (1994) Role of Bcl 2 and IL-5 in the regulation of anti-IgM induced growth arrest and apoptosis in immature B cell lines—a cooperative regulation model for B cell clonal deletion. J Immunol 152: 3294–3305
Kammer GM (1988) The adenylate cyclase-cAMP-protein kinase A pathway and regulation of the immune response. Immunol Today 9: 222–229
Kanazashi S, Hata D, Ishigami T, Jung EY, Shintaku N, Sumimoto S, Heike T, Katamura K, Mayumi M (1994) Induction of phosphatidylinositol turnover and Egr-1 messenger RNA expression by crosslinking of surface IgM and IgD in the human B-cell line-B104. Mol Immunol 31: 21–30
Kelly K, Cochran BH, Stiles CD, Leder P (1983) Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factors. Cell 35: 603–610
King LB, Ashwell JD (1993) Signaling for death of lymphoid cells. Curr Opin Immunol 51: 368–373
Kishihara K, Penninger J, Wallace VA, Kundig TM, Kawai K, Wakeham A, Timms E, Pfeffer K, Ohashi PS, Thomas ML, Furlonger C, Paige CJ, Mak TW (1993) Normal B-lymphocyte development but impaired T-cell maturation in CD45-exon6 protein tyrosine phosphatase-deficient mice. Cell 74: 143–156
Kitamura D, Kaneko H, Miyagoe Y, Ariyasu T, Watanabe T (1989) Isolation and characterization of a novel human gene expressed specifically in the cells of hematopoietic lineage. Nucleic Acids Res 17: 9367–9379
Knox KA, Gordon J (1993) Protein tyrosine phosphorylation is mandatory for CD40-mediated rescue of germinal center B-cells from apoptosis. Eur J Immunol 23: 2578–2584
Knox KA, Finney M, Milner AE, Gregory CD, Wakelam MJO, Micheli RH, Gordon J (1992) 2nd-messenger pathways involved in the regulation of survival in germinal centre B cells and in Burkitt lymphoma lines. Int J Cancer 52: 959–966
Knox KA, Johnson CD, Gordon J (1993) Distribution of cAMP in secondary follicles and its expression in B-cell apoptosis and CD40-mediated survival. Int Immunol 5: 1085–1091
Korsmeyer SJ (1992) Bcl-2—A repressor of lymphocyte death. Immunol Today 13: 285–288
Krammer PH, Behrmann I, Daniel P, Dhein J, Debatin K-M (1994) Regulation of apoptosis in the immune system. Curr Opin Immunol 6: 279–289
Lederman S, Yellin MJ, Covey LR, Cleary AM, Callard R, Chess L (1993) Nonantigen signals for B-cell growth and differentiation to antibody secretion. Curr Opin Immunol 5: 439–444
Lederman S, Yellin MJ, Cleary AM, Pernis A, Inghirami G, Cohn LE, Covey LR, Lee JJ, Rothman P, Chess L (1994) T-Bam/CD40-L on helper T lymphocytes augments lymphokine-induced B cell Ig isotype switch recombination and rescues B cells from programmed cell death. J Immunol 152: 2163–2171
Lee MR, Liou ML, Liou ML, Yang YF, Lai MZ (1993) cAMP analogs prevent activation-induced apoptosis of T-cell hybridomas. J Immunol 151: 5208–5217
Levy Y, Brouet JC (1994) Interleukin-10 prevents spontaneous death of germinal center B cells by induction of the Bcl-2 protein. J Clin Invest 93: 424–428
Liou LB, Warner GL, Scott DW (1992) Can peritoneal B-cells be rendered unresponsive. Int Immunol 4: 15–21
Liu YJ, Joshua DE, Williams GT, Smith CA, Gordon J, MacLennan ICM (1989) Mechanism of antigen-driven selection in germinal centres. Nature 342: 929–931
Liu YJ, Mason DY, Johnson GD, Abbot S, Gregory CD, Hardie DL, Gordon J, MacLennan ICM (1991) Germinal center cells express bcl-2 protein after activation by signals which prevent their entry into apoptosis. Eur J Immunol 21: 1905–1910
Mangan DF, Robertson B, Wahl SM (1992) IL-4 enhances programmed cell death (apoptosis) in stimulated human monocytes. J Immunol 148: 1812–1816
Mapara MY, Bargou R, Zugck C, Dohner H, Ustaoglu F, Jonker RR, Krammer PH, Dorken B (1993) APO-1 mediated apoptosis or proliferation in human chronic B-lymphocytic leukemia. Correlation with bcl-2 oncogene expression. Eur J Immunol 23: 702–708
Marquez C, Martinez C, Kroemer G, Bosca L (1992) Protein kinase-C isoenzymes display differential affinity for phorbol esters. Analysis of phorbol ester receptors in B-cell differentiation. J Immunol 149: 2560–2568
Matsuo T, Nomura J, Kuwahara K, Igarashi H, Inui S, Hamaguchi M, Kimoto M, Sakaguchi N (1993) Cross-linking of B-cell receptor-related MB-1 molecule induces protein tyrosine phosphorylation in early B-lineage cells. J Immunol 150: 3766–3775
McConkey DJ, Orrenius S, Jondal M (1990) Cellular signalling in programmed cell death (apoptosis). Immunol Today 11: 120–121
McConkey DJ, Aguilar-Santelises M, Hartzell P, Eriksson I, Mollstedt H, Orrenius S, Jondal M (1991) Induction of DNA fragmentation in chronic B-lymphocytic leukemia cells. J Immunol 146: 1072–1076
McConkey DJ, Orrenius S, Okret S, Jondal M (1993) Cyclic AMP potentiates glucocorticoid-induced endogenous endonuclease activation in thymocytes. FASEB J 7: 580–585
Melchers F, Karasuyama H, Haasner D, Bauer S, Kudo A, Sakaguchi N, Jameson B, Rolink A (1993) The surrogate light chain in B-cell development. Immunol Today 14: 60–68
Merino R, Ding LY, Veis DJ, Korsmeyer SJ, Nunez G (1994) Developmental regulation of the Bcl-2 protein and susceptibility to cell death in B-lymphocytes. EMBO J 13: 683–691
Metcalf ES, Klinman NR (1977) In vitro tolerance of bone marrow cells: a marker for B cell maturation. J Immunol 118: 2111–2116
Metzger H (1992) Transmembrane signaling: the joy of aggregation. J Immunol 149: 1477–1487
Milner AE, Grand RJA, Waters CM, Gregory CD (1993) Apoptosis in Burkitt lymphoma cells is driven by c-myc. Oncogene 8: 3385–3391
Mire-Sluis AR, Thorpe R (1991) Interleukin-4 proliferative signal transduction involves the activation of a tyrosine-specific phosphatase and the dephosphorylation of an 80-kDa protein. J Biol Chem 266: 18113–18118
Misener V, Downey GP, Jongstra J (1991) The immunoglobulin light chain related protein lambda 5 is expressed on the surface of mouse pre-B-cell lines and can function as a signal transducing molecule. Int Immunol 3: 1129–1136
Mizuguchi J, Yong-Yong J, Nakabayaschi H, Huang K-P, Beaven MA, Chused T, Paul WE (1987) Protein kinase C activation blocks anti-lgM-mediated signaling in BAL 17 B lymphoma cells. J Immunol 139: 1054–1059
Mond JJ, Feuerstein N, Finkelman FD, Huang F, Huang K-P. Dennis G (1987) B-lymphocyte activation mediated by anti-immunoglobulin antibody in the absence of protein kinase C. Proc Natl Acad Sci USA 84: 8588–8592
Mongini PKA, Blessinger CA, Dalton JP, Seki T (1992) Differential effects of cyclosporin A on diverse B cell activation phenomena triggered by crosslinking of membrane IgM. Cell Immunol 140: 478–494
Morris DL, Rothstein TL (1993) Abnormal transcription factor induction through the surface immunoglobulin-M receptor of lymphocytes-B 1. J Exp Med 177: 857–861
Motyka B, Griebel PJ, Reynolds JD (1993) Agents that activate protein kinase C rescue sheep ileal Peyer’s patch B-cells from apoptosis. Eur J Immunol 23: 1314–1321
Murakami M, Tsubata T, Okamoto M, Shimizu A, Kumagai S, Imura H, Honjo T (1992) Antigen-induced apoptotic death of Ly-1 B cells responsible for autoimmune disease in transgenic mice. Nature 357: 77–80
Muthukkumar S, Udhayakumar V, Bondada S (1993) Elevation ot cytosolic calcium is sufficient to induce growth inhibition in a B-cell lymphoma. Eur J Immunol 23: 2419–2426
Muthusamy N, Bondada S (1993) Differential regulation of surface immunoglobulin and Lyb2 mediated B-cell activation 2. cAMP dependent (Prostaglandin-E2) and independent (IFN-gamma) mechanisms of regulation of B-lymphocyte activation. Int Immunol 5: 949–956
Nakamura T, Sekar MC, Kubagawa H, Cooper MD (1993) Signal transduction in human B cells initiated via Ig beta ligation. Int Immunol 5: 1309–1315
Nakayama K, Nakayama K, Negishi I, Kuida K, Shinkai Y, Louie MC, Fields LE, Lucas PJ, Stewart V, Alt FW, Loh DY (1993) Disappearance of the lymphoid system in Bcl-2 homozygous mutant chimeric mice. Science 261: 1584–1588
Nemazee DA (1993) Promotion and prevention of autoimmunity by B-lymphocytes. Curr Opin Immunol 5: 866–872
Nemazee DA, Bürki K (1989a) Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes. Nature 337: 562–566
Nemazee DA, Bürki K (1989b) Clonal deletion of autoreactive B lymphocytes in bone marrow chimeras. Proc Natl Acad Sci USA 86: 8039–8043
Newell MK, Vandemall J, Beard KS, Freed JH (1993) Ligation of major histocompatibility complex Class-II molecules mediates apoptotic cell death in resting B-lymphocytes. Proc Natl Acad Sci USA 90: 10459–10463
Nisitani S, Tsubata T, Murakami M, Okamoto M, Honjo T (1993) The bcl-2 gene product inhibits clonal deletion of self-reactive B-lymphocytes in the periphery but not in the bone marrow. J Exp Med 178: 1247–1254
Noelle RJ, Ledbetter JA, Aruffo A (1992) CD40 and its ligand, an essential ligand-receptor pair for thymus-dependent B-cell activation. Immunol Today 13: 431–433
Nossal GJV (1983) Cellular mechanisms of immunological tolerance. Annu Rev Immunol 1: 33–62
Nossal GJV (1994) Negative selection of lymphocytes. Cell 76: 229–239
Nossal GJV, Pike BL (1975) Evidence for the clonal abortion theory of B lymphocyte tolerance. J Exp Med 141: 904–917
Nossal GJV, Pike BL (1980) Clonal anergy: persistence in tolerant mice of antigen-binding B lymphocytes incapable of responding to antigen or mitogen. Proc Natl Acad Sci USA 87: 1602–1606
Ogimoto M, Katagiri T, Mashima K, Hasegawa K, Mizuno K, Yakura H (1994) Negative regulation of apoptotic death in immature B cells by CD45. Int Immunol 6: 647–654
Parker DC (1975) Stimulation of mouse lymphocytes by insoluble anti-mouse immunoglobulin. Nature 258: 361–363
Parry SL, Holman MJ, Hasbold J, Klaus GGB (1994a) Plastic-immobilized anti-mu or anti-delta antibodies induce apoptosis in mature murine B lymphocytes. Eur J Immunol 24: 974–979
Parry SL, Hasbold J, Holman M, Klaus GGB (1994b) Hypercross-linking surface IgM or IgD receptors on mature B cells induces apoptosis that is reversed by costimulation with IL-4 and anti-CD40. J Immunol 152: 2821–2829
Phipps RP, Lee D, Schad V, Warner CL (1989) E-series prostaglandins are potent growth inhibtors for some B lymphomas. Eur J Immunol 19: 995–1001
Phipps RP, Roper RL, Stein SH (1990) Regulation of B-cell tolerance and triggering by macrophages and lymphoid dendritic cells. Immunol Rev 117: 135–158
Pure E, Vitetta E (1980) Induction of murine B cell proliferation by insolubilized anti-immunoglobulins. J Immunol 125: 1240–1242
Radic MZ, Erikson J, Litwin S, Weigert M (1993) B-lymphocytes may escape tolerance by revising their antigen receptors. J Exp Med 177: 1165–1173
Reed JC (1994) Bcl-2 and the regulation of programmed cell death. J Cell Biol 124: 1–6
Ren CL, Morio T, Fu SM, Geha RS (1994) Signal transduction via CD40 involves activation of Lyn kinase and phosphatidylinositol 3-kinase, and phosphorylation ot phospholipase C gamma 2. J Exp Med 179: 673–680
Reth M (1992) Antigen receptors on B lymphocytes. Annu Rev Immunol 10: 97–121
Reth M (1994) B cell antigen receptors. Curr Opin Immunol 6: 3–8
Rolink A, Melchers F (1991) Molecular and cellular origins of B lymphocyte diversity. Cell 66: 1081–1094
Roper RL, Phipps RP (1992) Prostaglandin-E2 and cAMP inhibit lymphocyte-B activation and simultaneously promote IgE and lgG1 synthesis. J Immunol 149: 2984–2991
Rubin LL, Philpott KL, Brooks SF (1993) The cell cycle and cell death. Curr Biol 3: 391–394
Sarthou P, Henry-Toulmé N, Cazenave P-A (1989) Membrane IgM cross-linking is not coupled to protein kinase C translocation in WEHI-231 B lymphoma cells. Eur J Immunol 19: 1247–1252
Schad VC, Phipps RP (1988) Two signals are required for accessory cells to induce B cell unresponsiveness. Tolerogenic Ig and prostaglandin. J Immunol 141: 79–84
Schreiber SL, Crabtree GR (1992) The mechanism of action of cyclosporin A and FK506. Immunol Today 13: 136–142
Schwartz LM, Osborne BA (1993) Programmed cell death, apoptosis and killer genes. Immunol Today 14: 582–590
Schwartz RS, Stollar BD (1994) Heavy-chain directed B-cell maturation: continuous clonal selection beginning at the pre-B cell stage. Immunol Today 15: 27–32
Scott DW, O’Garra A, Warren D, Klaus GGB (1987) Lymphoma models for B cell activation and tolerance-VI. Reversal of anti-Ig mediated negative signaling by T cell-derived lymphokines. J immunol 139: 3924–3929
Shi Y, Glynn JM, Guilbent LJ, Cotter TG, Bissonnette RP, Green DR (1992) Role for c-myc inactivation-induced apoptotic cell death in T cell hybridoma. Science 257: 212–214
Strasser A, Harris AW, Corcoran LM, Cory S (1994) Bcl-2 expression promotes B-lymphoid but not T-lymphoid development in seid mice. Nature 368: 457–460
Taga K, Cherney B, Tosato G (1993) IL-10 inhibits apoptotic cell death in human T cells starved of IL-2. Int Immunol 5: 1599–1608
Terajima J, Tsutsumi A, Freiremoar J, Cherwinski HM, Ransom JT (1992) Evidence for clonal heterogeneity of the expression of 6 protein kinase C isoforms in murine-B and lymphocytes T. Cell Immunol 142: 197–206
Tiegs SL, Russell DM, Nemazee D (1993) Receptor-editing in self-reactive bone marrow B cells, J Exp Med 177: 1009–1020
Tisch R, Roifman CM, Hozumi N (1988) Functional differences between immunoglobulins M and D expressed on the surface of an immature B-cell line. Proc Natl Acad Sci USA 85: 6914–6918
Trauth BC, Klas C, Peters AMJ, Matzku S, Möller P, Falk W, Debatin K-M, Krammer PH (1989) Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 245: 301–305
Trump BF, Berezesky IK (1992) The role of cytosolic Ca2+ in cell injury, necrosis and apoptosis. Curr Opin Cell Biol 4: 227–232
Tsubata T, Wu J, Honjo T (1993) B-cell apoptosis induced by antigen receptor crosslinking is blocked by a T-cell signal through CD40. Nature 364: 645–648
Tsubata T, Murakami M, Honjo T (1994) Antigen-receptor cross-linking induces peritoneal B-cell apoptosis in normal but not autoimmunity-prone mice. Curr Biol 4: 8–17
Tsutsumi A, Terajima J, Jung WM, Ransom J (1992a) Surface mu heavy chain expressed on pre B lymphomas transduces Ca2+ signals but fails to cause growth arrest of pre-B lymphomas. Cell Immunol 139: 44–57
Tsutsumi A, Freiremoar J, Ransom JT (1992b) Transient down-regulation of PKC-zeta RNA following crosslinking of membrane IgM on WEHI-231 B-lymphoma cells. Cell Immunol 142: 303–312
Udhayakumar V, Kumar L, Subbarao B (1991a) The influence of avidity on signaling murine lymphocytes-B with monoclonal anti-IgM antibodies—Effects on B-cell proliferation versus growth inhibition (tolerance) of an immature B-cell lymphoma. J Immunol 146: 4120–4129
Udhayakumar V, Muthukkumar S, Subbarao B (1991b) Cyclosporin-A blocks surface IgM-mediated growth inhibition in an immature B-lymphoma, BKS-2. Eur J Immunol 21: 2605–2608
Valentine MA, Licciardi KA (1992) Rescue from anti-IgM-induced programmed cell death by the B-cell surface proteins CD20 and CD40. Eur J Immunol 22: 3141–3148
Van Endert PM, Moldenhauer G (1992) Inhibitory and stimulatory signaling via immunoglobulin receptors. Dichotomous responses elicited in clonal B-cell populations. Eur J Immunol 22: 1229–1235
Veis DJ, Sentman CL, Bach EA, Korsmeyer SJ (1993a) Expression of the Bcl-2 protein in murine and human thymocytes and in peripheral T-lymphocytes. J Immunol 151: 2546–2554
Veis DJ, Sorenson CM, Shutter JR, Korsmeyer SJ (1993b) Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 75: 229–240
Wade WF, Davoust J, Salamero J, Andre P, Watts TH, Cambier JC (1993) Structural compartmentalization of MHC Class-II signaling function. Immunol Today 14: 539–546
Warner GL, Scott DW (1988) Lymphoma models for B-cell activation and tolerance-VII. Pathways in anti-lg-mediated growth inhibition and its reversal. Cell Immunol 115: 195–203
Wheeler K, Pound JD, Gordon J, Jefferis R (1993) Engagement of CD40 lowers the threshold for activation of resting B-cells via antigen receptor. Eur J Immunol 23: 1165–1168
Williams GT, Smith CA (1993) Molecular regulation of apoptosis: genetic controls on cell death. Cell 74: 777–779
Yamanashi Y, Okada M, Semba T, Yamori T, Umemori H, Tsunasawa S, Toyoshima K, Kitamura D, Watanabe T, Yamamoto T (1993) Identification of HS 1 protein as a major substrate of proteintyrosine kinase(s) upon B-cell antigen receptor-mediated signaling. Proc Natl Acad Sci USA 90: 3631–3635
Yao XR, Scott DW (1993) Antisense oligodeoxynucleotides to the blk tyrosine kinase prevent anti-mu chain-mediated growth inhibition and apoptosis in a B-cell lymphoma. Proc Natl Acad Sci USA 90: 7946–7950
Yellen AJ, Glenn W, Sukhatme VP, Cao XM, Monroe JG (1991) Signaling through surface IgM in tolerance-susceptible immature murine B-lymphocytes. Developmentally regulated differences in transmembrane signaling in splenic B-cells from adult and neonatal mice. J Immunol 146: 1446–1454
Yellen-Shaw A, Monroe JG (1992) Differential responsiveness of immature-stage and mature-stage murine B cells to anti-IgM reflects both FcR-dependent and FcR-independent mechanisms. Cell Immunol 145: 339–350
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Sarthou, P., Benhamou, L., Cazenave, PA. (1995). B Cell Activation and Apoptosis. In: Kroemer, G., Martinez-A., C. (eds) Apoptosis in Immunology. Current Topics in Microbiology and Immunology, vol 200. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-79437-7_2
Download citation
DOI: https://doi.org/10.1007/978-3-642-79437-7_2
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-79439-1
Online ISBN: 978-3-642-79437-7
eBook Packages: Springer Book Archive